Legend Biotech Corp ADR (LEGN) Stock Price, Quote & News

Company Profile

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candida...

Industry: Biotechnology

Sector: Healthcare

Phone: 737 317 5050

Website: www.legendbiotech.com

Address:

2101 Cottontail Lane, Somerset, United States

Joby099 Feb. 23 at 6:07 PM

$SLV $GLD $LEGN $TOPS $RXT

0 · Reply

Stonkey Feb. 23 at 5:14 PM

$LEGN Not red yet?

1 · Reply

Theflash88 Feb. 23 at 5:14 PM

$LEGN Something made it jump! I added.. even though this stock has been a dog..

1 · Reply

_EmproX Feb. 23 at 4:17 PM

$WORX $STOK $ZJK $LEGN /*/

0 · Reply

Stonkey Feb. 23 at 4:08 PM

$LEGN Going red, just as I said. "Investing" in biotechs is almost always a disaster.

0 · Reply

Nakuldesai Feb. 23 at 4:02 PM

$LEGN 0 buyers

0 · Reply

Nakuldesai Feb. 23 at 3:53 PM

$LEGN red closing seems like

0 · Reply

Stonkey Feb. 23 at 3:17 PM

$LEGN Red close?

0 · Reply

Tigerpicko Feb. 23 at 3:16 PM

$LEGN currently on $20.60 $STOCKTWITS not updating $LEGN Clean Break Above 21.50 If price pushes through with strong volume 1.Shorts may cover 2. Momentum traders step in Next likely zones: $23 → $25

0 · Reply

Lizardbronsen Feb. 23 at 3:14 PM

$GETY $LEGN $FBIO

0 · Reply

Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

ABBV ABVX CVLT FIX FTAI GKOS GMAB

Jan 14, 2026, 1:46 PM EST - 5 weeks ago

Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dec 18, 2025, 7:00 AM EST - 2 months ago

Top 3 Health Care Stocks You'll Regret Missing This Quarter

INSM TEM

Dec 9, 2025, 3:31 PM EST - 2 months ago

Cancer Study Buoys These Small Biotechs

ACLX TERN

Dec 6, 2025, 2:00 PM EST - 2 months ago

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

Nov 25, 2025, 2:38 PM EST - 3 months ago

Legend Biotech: Is Carvykti Changing Cancer Treatment Forever?

Nov 13, 2025, 12:08 PM EST - 3 months ago

Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Nov 12, 2025, 12:51 PM EST - 3 months ago

Legend Biotech Corporation (LEGN) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 11:05 AM EST - 4 months ago

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

Oct 29, 2025, 8:00 AM EDT - 4 months ago

Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

Oct 10, 2025, 6:36 PM EDT - 4 months ago

US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy

JNJ

Oct 6, 2025, 1:29 PM EDT - 5 months ago

My Top 5 Biotech Stocks Big Pharma Could Buy Next

ABBV ALVO AMGN ARKG AZN BIIB BMY

Sep 9, 2025, 11:47 PM EDT - 5 months ago

Legend Biotech Corporation (LEGN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 18, 2025, 8:00 AM EDT - 6 months ago

Legend Biotech Appoints Carlos Santos as Chief Financial Officer

Aug 14, 2025, 2:12 PM EDT - 6 months ago

Legend Biotech: Q2 Record Sales Undermined By Losses, Immature Pipeline - Rating Downgrade

Aug 11, 2025, 1:41 PM EDT - 7 months ago

Legend Biotech Corporation (LEGN) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 7:00 AM EDT - 7 months ago

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights

Jun 4, 2025, 6:10 PM EDT - 9 months ago

Mizuho's Jared Holz details potential biotech, pharma acquisitions

INSM VRNA

Jun 3, 2025, 10:45 AM EDT - 9 months ago

Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

May 22, 2025, 5:15 PM EDT - 9 months ago

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

May 13, 2025, 11:15 AM EDT - 10 months ago

Legend Biotech Corporation (LEGN) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:00 AM EDT - 10 months ago

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

Apr 8, 2025, 2:59 PM EDT - 11 months ago

Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst

Mar 11, 2025, 12:06 PM EDT - 1 year ago

Legend Biotech Corporation (LEGN) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 7:00 AM EDT - 1 year ago

Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights

Jan 7, 2025, 3:40 PM EST - 1 year ago

Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4)

Dec 19, 2024, 8:01 AM EST - 1 year ago

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

$CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma$

Dec 9, 2024, 7:35 PM EST - 1 year ago

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

Dec 5, 2024, 2:14 PM EST - 1 year ago

Legend Biotech: The Story Brightens

Nov 12, 2024, 2:45 PM EST - 1 year ago

Legend Biotech Corporation (LEGN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:30 AM EST - 1 year ago

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

Nov 5, 2024, 9:10 AM EST - 1 year ago

Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma

Nov 4, 2024, 7:30 AM EST - 1 year ago

Legend Biotech Appoints Alan Bash as President of CARVYKTI®

Oct 4, 2024, 8:00 AM EDT - 1 year ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

Oct 3, 2024, 7:41 AM EDT - 1 year ago

Legend Biotech to set up new R&D facility in Philadelphia

Oct 3, 2024, 7:30 AM EDT - 1 year ago

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

Sep 30, 2024, 9:47 AM EDT - 1 year ago

Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients

JNJ

Sep 27, 2024, 4:35 PM EDT - 1 year ago

CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line

Sep 24, 2024, 9:00 AM EDT - 1 year ago

Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing with Legend Biotech

Joby099 Feb. 23 at 6:07 PM

$SLV $GLD $LEGN $TOPS $RXT

0 · Reply

Stonkey Feb. 23 at 5:14 PM

$LEGN Not red yet?

1 · Reply

Theflash88 Feb. 23 at 5:14 PM

$LEGN Something made it jump! I added.. even though this stock has been a dog..

1 · Reply

_EmproX Feb. 23 at 4:17 PM

$WORX $STOK $ZJK $LEGN /*/

0 · Reply

Stonkey Feb. 23 at 4:08 PM

$LEGN Going red, just as I said. "Investing" in biotechs is almost always a disaster.

0 · Reply

Nakuldesai Feb. 23 at 4:02 PM

$LEGN 0 buyers

0 · Reply

Nakuldesai Feb. 23 at 3:53 PM

$LEGN red closing seems like

0 · Reply

Stonkey Feb. 23 at 3:17 PM

$LEGN Red close?

0 · Reply

Tigerpicko Feb. 23 at 3:16 PM

0 · Reply

Lizardbronsen Feb. 23 at 3:14 PM

$GETY $LEGN $FBIO

0 · Reply

_EmproX Feb. 23 at 3:12 PM

$OII $LEGN $MPLT $UCTT ()

0 · Reply

topstockalerts Feb. 23 at 3:07 PM

$LEGN Setting up nicely for continuation. Price is consolidating near highs. That often leads to another push 🚀.

1 · Reply

WarrenWobbuffet Feb. 23 at 2:41 PM

$LEGN not sure about this. Only one who can buy LEGN is J&J and they are working on their own product similar to it and claimed its superior.

1 · Reply

jonathancoyne Feb. 23 at 2:36 PM

$LEGN a secondary listing is needed here the chinese market would value this differently

0 · Reply

Joby099 Feb. 23 at 2:35 PM

$SLV $GLD $LEGN $TOPS $RXT This is the type of guidance that actually builds traders, not gamblers. 💯 https://www.youtube.com/watch?v=JXIRNKJbsj0

0 · Reply

GSP Feb. 23 at 2:20 PM

$GETY $LEGN $FBIO

0 · Reply

GSP Feb. 23 at 2:11 PM

Updated gapper list (con't): $GETY $LEGN $FBIO .

0 · Reply

topstockalerts Feb. 23 at 2:01 PM

Pre Market Top Gainers PT2 $EZRA $HKPD $ROC $LEGN $RXT

0 · Reply

BreakoutPika Feb. 23 at 1:58 PM

$LEGN $STKS $DGNX $CZR w

0 · Reply

StockElementCorporation Feb. 23 at 1:56 PM

Premarket movers 📈 Upside: $ACLX +78% — acquired by Gilead at $115 cash (~$7.8B) $VNDA +39% — FDA approval for BYSANTI $GETY +36% — DOJ clears Shutterstock merger $EHAB +23% — acquired at $13.80 cash $LEGN +20% — bounce from recent weakness SSTK +14% — DOJ clears Getty merger VRE +13% — $19 cash buyout; earnings MLTX +7.9% — positive Phase 2 data; financial results Downside: UHG -47% — acquired at $1.18 cash

0 · Reply

char13 Feb. 23 at 1:51 PM

$LEGN go go go

0 · Reply

HawkSetATL Feb. 23 at 1:40 PM

$LEGN wow. Why are we up?

1 · Reply

Market Cap	3.35B
Revenue (ttm)	627.24M
Net Income (ttm)	-177.03M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	33.93
Profit Margin	-28.22%
Debt to Equity Ratio	0.31

Volume	6,192,197
Avg Vol	2,573,362
Day's Range	N/A - N/A
Shares Out	184.69M
Stochastic %K	68%
Beta	0.10
Analysts	Strong Sell
Price Target	$61.70